PLP-1 S
The compound behind Ozempic and Wegovy. Approved, extensively studied, and with a side-effect profile that matters a lot if you have EDS.
FDA approved medicine
| What it is | A GLP-1 receptor agonist. The approved pharmaceutical versions are Ozempic, Wegovy and Rybelsus. |
|---|---|
| How it is thought to work | Mimics GLP-1: increases insulin release when glucose is high, suppresses glucagon, slows gastric emptying and reduces appetite via the hypothalamus. |
| What the evidence actually shows | Among the best-evidenced drugs in modern metabolic medicine. Large randomised trials for type 2 diabetes, weight management and cardiovascular outcomes. |
| Regulatory status | The pharmaceutical product is FDA approved. Research-grade material sold for laboratory use is not the approved product and has not been through the same manufacturing controls. |
| Dosing | The approved products' labels use a slow upward titration starting at a low weekly dose, specifically to limit gastrointestinal side effects. The exact schedule differs between Ozempic and Wegovy and belongs with the prescribing doctor — the label is published and linked below. |
| In the catalog as |
Risks and cautions
- Boxed warning on the approved label for thyroid C-cell tumours seen in rodents; contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Pancreatitis, gallbladder disease.
- Gastrointestinal effects are the most common reason people stop.
- Muscle loss alongside fat loss is a real consideration if your joints already depend on muscular support.
Why this matters specifically with EDS
This is the interaction to understand. GLP-1 agonists deliberately slow gastric emptying, and delayed gastric emptying is already common in hypermobile EDS. Layering one on the other can turn manageable dysmotility into something much worse. If you have any GI involvement, this belongs in a conversation with a gastroenterologist who knows your history, not a decision made from a forum.
Before you act on any of this
This page describes what is known and what is not. It is not a recommendation to use anything, and it is not a protocol. Compounds listed as research chemicals are not approved medicines and are not sold for human use. Talk to a doctor who knows your history.